COVI-VAC
candidate vaccine against COVID-19
Press Enter · cited answer in seconds
0 sources
COVI-VAC
Summary
COVI-VAC ranks in the top 2% of general entities by monthly Wikipedia readership (8 views/month).[1]
Key Facts
- COVI-VAC's developer is recorded as Codagenix (United States)[2].
- COVI-VAC's subclass of is recorded as COVID-19 vaccine[3].
- COVI-VAC's subclass of is recorded as vaccine[4].
- COVI-VAC's route of administration is recorded as nasal administration[5].
Why It Matters
COVI-VAC ranks in the top 2% of general entities by monthly Wikipedia readership (8 views/month).[1] COVI-VAC has Wikipedia articles in 5 language editions, a strong signal of global cultural recognition.[6]